GlycoEra is a Biotech company based in Schlieren, Switzerland. It has raised $179M in total funding. Latest round: Series B.
GlycoEra is a Biotech company based in Schlieren, Switzerland. GlycoEra has raised $179M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for GlycoEra runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings, Catalio Capital Management, LifeArc Ventures, Qatar Investment Authority, Sofinnova Partners, 5AM Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
GlycoEra totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Schlieren below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026